Brachytherapy plus EBRT reduces the risk of ECE in prostate cancer patients

被引：0
|
作者：
机构：
来源：
Nature Clinical Practice Urology | 2007年 / 4卷 / 6期
关键词：
D O I：
10.1038/ncpuro0790
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：295 / 295
相关论文
共 50 条
  • [41] Quality of Life, Treatment Toxicity, and Biochemical Control in Patients Treated with Dose-Escalation Brachytherapy and EBRT for Intermediate- and High-Risk Prostate Cancer
    Pierson, C.
    Saxena, S.
    Kelly, S.
    Ju, A. W.
    Chen, R. C.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E596 - E596
  • [42] Comparison of Permanent Seed Implant Monotherapy With Combined EBRT Plus HDR Boost in Intermediate-Risk Prostate Cancer
    Vigneault, E.
    Martin, A.
    Foster, W.
    Aubin, S.
    Despres, P.
    Beaulieu, L.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S432 - S432
  • [43] The risk of second primary malignancies following brachytherapy monotherapy, external beam plus brachytherapy, or radical prostatectomy for prostate cancer
    Tward, J. D.
    Sylvester, J. E.
    Grimm, P. D.
    Shrieve, D. C.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (01): : S94 - S94
  • [44] Vaccine combined with EBRT effective for patients with localized prostate cancer
    [J]. Nature Clinical Practice Urology, 2005, 2 (7): : 313 - 313
  • [45] Chronic Lower Extremity Lymphedema in Gynecologic Cancer Patients : EBRT versus Brachytherapy
    Chang, W. I.
    Kang, H.
    Kim, H. J.
    Seo, K. S.
    Kim, H. S.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2019, 133 : S434 - S434
  • [46] PSA-KINETICS FOLLOWING EXTERNAL BEAM RADIOTHERAPY (EBRT), TEMPORARY INTERSTITIAL BRACHYTHERAPY AS A BOOST TO EBRT (HDR-BT) AND PERMANENT INTERSTITIAL BRACHYTHERAPY AS BRACHYTHERAPY (LDR-BT) FOR PROSTATE CANCER
    Pinkawa, M.
    Holy, R.
    Piroth, M.
    Klotz, J.
    Borchers, H.
    Eble, M.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2009, 91 : S54 - S54
  • [47] Brachytherapy Alone (BT) Without Supplemental External Beam Radiation Therapy (EBRT) May be Sufficient in Management of Intermediate Risk Prostate Cancer
    Shah, Amit
    Bell, Ted
    Fortier, Gregory
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2010, 33 (02): : 210 - 210
  • [48] HIGH DOSE RATE (HDR) BRACHYTHERAPY plus EXTERNAL BEAM RADIOTHERAPY (EBRT) FOR HORMONE-NAIVE EARLY AND INTERMEDIATE STAGE PROSTATE CANCER.
    Aluwini, S.
    van Rooij, P.
    Janson, P.
    Kirkels, W.
    Praag, J.
    Bangma, C.
    Kolkman-Deurloo, I. K.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2010, 96 : S214 - S214
  • [49] Combined use of goldmarkers for setup in fractionated HDR brachytherapy (BT) and organtracking during EBRT of prostate cancer
    Aebersold, DM
    Kolotas, C
    Isaak, B
    Thalmann, G
    Vetterli, D
    Kernmerling, L
    Behrensmeier, F
    Mini, R
    Greiner, RH
    [J]. STRAHLENTHERAPIE UND ONKOLOGIE, 2004, 180 : 101 - 101
  • [50] HDR brachytherapy combined to EBRT for prostate cancer: analysis of toxicities and PSA bounce of a phase II trial
    Tetreault-Laflamme, A.
    Nguyen, T. V.
    Vincent, F.
    Saad, F.
    Benoit, N.
    Fortin, B.
    Lambert, C.
    Jolicoeur, M.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2015, 115 : S566 - S566
12345